171 related articles for article (PubMed ID: 30243004)
1. Human Leukocyte Antigen-G (HLA-G) Expression in Precancerous and Cancerous Cervical Lesions: Association with Human Papilloma Virus Infection and Host Immune Response.
Fahim NM; Shehata IH; Taha SE; Fahmy RA; Elsayed MS
Egypt J Immunol; 2018 Jan; 25(1):125-134. PubMed ID: 30243004
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response.
Dong DD; Yang H; Li K; Xu G; Song LH; Fan XL; Jiang XL; Yie SM
Reprod Sci; 2010 Aug; 17(8):718-23. PubMed ID: 20445010
[TBL] [Abstract][Full Text] [Related]
3. Understanding HLA-G driven journey from HPV infection to cancer cervix: Adding missing pieces to the jigsaw puzzle.
Aggarwal R; Sharma M; Mangat N; Suri V; Bhatia T; Kumar P; Minz R
J Reprod Immunol; 2020 Nov; 142():103205. PubMed ID: 33099242
[TBL] [Abstract][Full Text] [Related]
4. Implication of HLA-G 3' untranslated region polymorphisms in human papillomavirus infection.
Bortolotti D; Gentili V; Rotola A; Di Luca D; Rizzo R
Tissue Antigens; 2014 Feb; 83(2):113-8. PubMed ID: 24397524
[TBL] [Abstract][Full Text] [Related]
5. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus.
Simões RT; Gonçalves MA; Castelli EC; Júnior CM; Bettini JS; Discorde ML; Duarte G; Quintana SM; Simões AL; Moreau P; Carosella ED; Soares EG; Donadi EA
Mod Pathol; 2009 Aug; 22(8):1075-82. PubMed ID: 19407850
[TBL] [Abstract][Full Text] [Related]
6. Expression of p16
Badiga S; Chambers MM; Huh W; Eltoum IA; Piyathilake CJ
Cancer; 2016 Dec; 122(23):3615-3623. PubMed ID: 27479745
[TBL] [Abstract][Full Text] [Related]
7. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
Chatterjee K; Dandara C; Hoffman M; Williamson AL
BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix.
Ferguson R; Ramanakumar AV; Koushik A; Coutlée F; Franco E; Roger M;
Int J Cancer; 2012 Aug; 131(3):E312-9. PubMed ID: 22095460
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the association of NKG2C copy number variations with susceptibility to human papillomavirus-induced cervical lesions.
Vilchez JR; Torres-Moreno D; Martínez-Senac MM; Trujillo-Santos J; Conesa-Zamora P
Hum Immunol; 2013 Oct; 74(10):1352-6. PubMed ID: 23911737
[TBL] [Abstract][Full Text] [Related]
11. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium.
Mota F; Rayment N; Chong S; Singer A; Chain B
Clin Exp Immunol; 1999 Apr; 116(1):33-40. PubMed ID: 10209502
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
Liu Y; Ang Q; Wu H; Xu J; Chen D; Zhao H; Liu H; Guo X; Gu Y; Qiu H
Virol J; 2020 Jul; 17(1):104. PubMed ID: 32660490
[TBL] [Abstract][Full Text] [Related]
13. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica.
Ung A; Kramer TR; Schiffman M; Herrero R; Bratti MC; Burk RD; Swanson CA; Sherman ME; Hutchinson ML; Alfaro M; Morales J; Balmaceda I; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):249-53. PubMed ID: 10090303
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix.
Chil A; Sikorski M; Bobek M; Jakiel G; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1146-52. PubMed ID: 14616262
[TBL] [Abstract][Full Text] [Related]
16. The Role of HLA-G in Human Papillomavirus Infections and Cervical Carcinogenesis.
Xu HH; Yan WH; Lin A
Front Immunol; 2020; 11():1349. PubMed ID: 32670296
[TBL] [Abstract][Full Text] [Related]
17. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
[TBL] [Abstract][Full Text] [Related]
18. [Human papillomavirus genotyping of cervical uterine preneoplastic lesions in a high risk area].
López M J; Ili G CG; Brebi M P; García M P; Capurro V I; Guzmán G P; Suárez P E; Ojeda F JM; Roa S JC
Rev Med Chil; 2010 Nov; 138(11):1343-50. PubMed ID: 21279245
[TBL] [Abstract][Full Text] [Related]
19. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection.
Glew SS; Connor ME; Snijders PJ; Stanbridge CM; Buckley CH; Walboomers JM; Meijer CJ; Stern PL
Eur J Cancer; 1993; 29A(14):1963-70. PubMed ID: 8280490
[TBL] [Abstract][Full Text] [Related]
20. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
